Abdominal Organ Transplant Center Tobacco Use Policies Vary by Organ Program Type

2016 ◽  
Vol 48 (6) ◽  
pp. 1920-1926 ◽  
Author(s):  
D.R. Cote ◽  
T.J. Chirichella ◽  
K.A. Noon ◽  
D.M. Shafran ◽  
J.J. Augustine ◽  
...  
Keyword(s):  
Tobacco Use ◽  
Organ Transplant ◽  
Abdominal Organ ◽  
Program Type ◽  
Transplant Center

Association of balanced abdominal organ transplant center volumes with patient outcomes

2021 ◽  
Author(s):  
Joel T. Adler ◽  
Thomas C. Tsai ◽  
Ginger Jin ◽  
David C. Cron ◽  
Katherine H. Ross‐Driscoll ◽  
...  
Keyword(s):  
Patient Outcomes ◽  
Organ Transplant ◽  
Abdominal Organ ◽  
Transplant Center

scholarly journals A pragmatic outreach pilot to understand and overcome barriers to COVID‐19 vaccination in abdominal organ transplant

2021 ◽  
Author(s):  
Marina Serper ◽  
Chung‐Heng Liu ◽  
Emily A. Blumberg ◽  
Alexander E. Burdzy ◽  
Stephanie Veasey ◽  
...  
Keyword(s):  
Organ Transplant ◽  
Abdominal Organ

scholarly journals Evaluation and Transplantation of a SARS-CoV-2 Seropositive Kidney Candidate

2021 ◽  
Vol 2021 ◽  
pp. 1-5
Author(s):  
Maya C. Graves ◽  
Sapna A. Mehta ◽  
Bonnie E. Lonze ◽  
Nicole M. Ali
Keyword(s):  
New York ◽  
Kidney Transplant Recipient ◽  
Organ Transplant ◽  
Laboratory Assessment ◽  
Transplant Center ◽  
History Of ◽  
Center Activity ◽  
Transplant Candidates ◽  
Living Donor Kidney Transplant ◽  
Or History

The COVID-19 pandemic affected transplant center activity in areas with high number of cases such as New York City and prompted reevaluation of patients awaiting organ transplant diagnosed with SARS-CoV-2 infection. To resume safe transplantation at our center, we found it necessary to (1) identify transplant candidates with possible exposure to or history of COVID-19 infection, (2) outline a clinical and laboratory assessment to determine adequate clinical recovery from COVID-19 for transplantation, and (3) determine whether the possibility of perioperative COVID-19 transmission from the patient to staff would pose unacceptable risk. Here, we describe our center’s approach to proceeding with transplantation in a SARS-CoV-2 seropositive living donor kidney transplant recipient and describe early posttransplant outcomes.

Recommendations From the Society for the Advancement of Transplant Anesthesiology Fellowship Committee: Core Competencies and Milestones for the Kidney/Pancreas Component of Abdominal Organ Transplant Anesthesia Fellowship

2021 ◽  
pp. 108925322110585
Author(s):  
Fouad G. Souki ◽  
Ryan Chadha ◽  
Raymond Planinsic ◽  
Jeron Zerillo ◽  
Christine Nguyen-Buckley ◽  
...  
Keyword(s):  
Core Competencies ◽  
Organ Transplant ◽  
Fellowship Training ◽  
Transplant Recipients ◽  
Abdominal Organ ◽  
Operative Techniques ◽  
Post Operative Pain ◽  
Operative Evaluation ◽  
Thoracic Transplantation ◽  
Improving Patient Care

The Society for the Advancement of Transplant Anesthesia (SATA) is dedicated to improving patient care in all facets of transplant anesthesia. The anesthesia fellowship training recommendations for thoracic transplantation (heart and lungs) and part of the abdominal organ transplantation (liver) have been presented in previous publications. The SATA Fellowship Committee has completed the remaining component of abdominal transplant anesthesia (kidney/pancreas) and has assembled core competencies and milestones derived from expert consensus to guide the education and overall preparation of trainees providing care for kidney/pancreas transplant recipients. These recommendations provide a comprehensive approach to pre-operative evaluation, vascular access procedures, advanced hemodynamic monitoring, assessment of coagulation and metabolic abnormalities, operative techniques, and post-operative pain control. As such, this document supplements the current liver/hepatic transplant anesthesia fellowship training programs to include all aspects of “Abdominal Organ Transplant Anesthesia” recommended knowledge.

Shiraz Organ Transplant Center

2019 ◽  
Vol 103 (8) ◽  
pp. 1523-1525 ◽  
Author(s):  
Seyed Ali Malek-Hosseini ◽  
Farrokh Habibzadeh ◽  
Saman Nikeghbalian
Keyword(s):  
Organ Transplant ◽  
Transplant Center

Cyclosporine Monitoring

1986 ◽  
Vol 20 (9) ◽  
pp. 649-652 ◽  
Author(s):  
Gilbert J. Burckart ◽  
Daniel M. Canafax ◽  
Gary C. Yee
Keyword(s):  
Bone Marrow ◽  
Drug Response ◽  
Organ Transplant ◽  
Marrow Transplant ◽  
Immunosuppressive Agent ◽  
Solid Organ ◽  
Routine Monitoring ◽  
Transplant Center ◽  
Patient Variables ◽  
Extreme Variability

Cyclosporine is an important immunosuppressive agent in organ and bone marrow transplantation. The pharmacokinetics of cyclosporine are quite complex and are complicated by the availability of two assay systems that yield differing results. This article summarizes the views from two major solid organ transplant centers and one bone marrow transplant center on important cyclosporine monitoring questions. A general consensus exists in the four areas discussed that: (1) cyclosporine concentrations must be monitored due in part to the extreme variability in kinetics, (2) either blood or plasma can be used in monitoring programs, (3) the radioimmunoassay or high pressure liquid chromatography can be used in routine monitoring, and (4) the interpretation of cyclosporine concentrations must be performed in relation to patient variables that affect drug response and toxicity.

scholarly journals The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients

2003 ◽  
Vol 37 (1) ◽  
pp. 27-31 ◽  
Author(s):  
Michael J. Englesbe ◽  
Audrey H. Wu ◽  
Alexander W. Clowes ◽  
R.Eugene Zierler
Keyword(s):  
Natural History ◽  
Organ Transplant ◽  
Aortic Aneurysms ◽  
Abdominal Organ ◽  
Transplant Patients ◽  
History Of
Sign in / Sign up

Export Citation Format

Share Document